Uniphar plc announced the appointment of Valerie Sick to its Board as an independent non-executive Director, with immediate effect. Valerie has over 25 years' senior international experience in private and publicly listed pharmaceutical and life science companies in Europe. She has held senior financial and management roles, including managing very diverse operations from a profitability and value creation point of view.

Valerie currently serves as Chief Financial Officer of bioMerieux Deutschland GmbH and previous appointments include Director of Finance and Administration of Yves Rocher GmbH and Global Process Owner - Finance for Celesio AG. She is highly experienced in strategic change management and integration across multiple countries and regions to foster growth, with extensive experience in managing multi-stakeholder engagement and strategic decision-making within complex regulated environments at global, regional and national levels. Valerie is fluent in French, German and English and also has a strong interest in climate friendly business models and long-term sustainable business.

The Company also announces the following non-executive director changes to the composition of the Committees of the Board with immediate effect: Valerie Sick has been appointed to the Nominations, Governance and Sustainability Committee and the Remuneration Committee. Paul Hogan has been appointed as Chair of the Remuneration Committee following the resignation of Jeffrey Berkowitz.